Trial Profile
Efficacy of acrabose + vildagliptin versus metformin + sulfonylurea in treatment naive patients with type 2 diabetes mellitus
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 15 Dec 2011
Price :
$35
*
At a glance
- Drugs Acarbose (Primary) ; Metformin (Primary) ; Vildagliptin (Primary) ; Sulfonylureas
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 15 Dec 2011 New trial record
- 08 Dec 2011 Results presented at the 21st World Diabetes Congress.